Fluticasone: all 234 studies that test it
Page 3 of 3. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPDCompletedNCT00535366Phase 2
- Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of ProphylaxisTerminatedNCT00524095Phase 2
- Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial AsthmaCompletedNCT00504062Phase 3
- Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)CompletedNCT00480649Phase 4
- No Resistance After Long Term Treatment SERETIDEWithdrawnNCT00456313Phase 4
- A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics PatientsCompletedNCT00453778Phase 4
- Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate AsthmaWithdrawnNCT00409630Not applicable
- Randomized Trial of Fluticasone in Bronchial PremalignancyCompletedNCT00407264Phase 2
- A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00403286Phase 2
- Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone PropionateCompletedNCT00400855Phase 2
- New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With AsthmaCompletedNCT00394121Phase 3
- Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.CompletedNCT00370591Phase 4
- FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old SubjectsCompletedNCT00370097Phase 1
- Spacer Comparison In Adult AsthmaticsCompletedNCT00369993Phase 2
- Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In AsthmaticsCompletedNCT00364442Phase 1
- Chronic Obstructive Pulmonary Disease Endpoints StudyCompletedNCT00358358Phase 4
- Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)CompletedNCT00348361Phase 1
- Viapaed Study In Children And Adolescents With AsthmaCompletedNCT00315744Phase 4
- Treatment of Persistent Wheezing in Infants and ChildrenCompletedNCT00301171Not applicable
- Study Of Patients With Allergic Rhinitis And AsthmaCompletedNCT00296530Phase 4
- Study In Asthma ControlTerminatedNCT00273026Phase 4
- A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic DisordersCompletedNCT00266578Phase 3
- Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239499Phase 4
- Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With AsthmaCompletedNCT00238927Phase 4
- Effect of an Inhaled Corticosteroid on Airway Gene Expression in AsthmaCompletedNCT00187499Not applicable
- Inhaled Steroid Reduces Systemic Inflammation in COPDCompletedNCT00175565Phase 4
- Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.CompletedNCT00169546Phase 4
- Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma MedicationsCompletedNCT00158834Phase 3
- Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic EsophagitisCompletedNCT00123656Phase 2
- Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled TrialStatus unknownNCT00120978Phase 4
- A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or ExerciseCompletedNCT00118690Phase 4
- A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD ExacerbationsCompletedNCT00116402Phase 1
- Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol XinafoateCompletedNCT00102882Phase 4
- Study Of Asthma In Patients Of African DescentCompletedNCT00102765Phase 4